article thumbnail

OIG Issues Special Fraud Alert Regarding Telemedicine Arrangements

Health Care Law Brief

On July 20, 2022, the Office of Inspector General for the Department of Health and Human Services (“ OIG ”) issued a special fraud alert (“ Alert ”) advising “practitioners to exercise caution when entering into arrangements with purported telemedicine companies.” OIG Flags Seven Characteristics of Telehealth Fraud.

Fraud 52
article thumbnail

2022 Telemental Health Regulations Unlock Access and Evolve Compliance Practices

HIT Consultant

As within many areas of health care, however, expansion and innovation contributed to a higher risk of fraud and resulted in an increase in enforcement activity. Telemental health providers were not immune to this activity in 2022, and providers should prioritize regulatory compliance as the industry looks ahead to 2023. “As

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Key Legal Issues Facing Telehealth Platforms, as Compliance Concerns Bubble for Platforms Launched During the Public Health Emergency

Health Care Law Brief

The onset of the COVID-19 public health emergency (“PHE”) led to a surge in the use of telehealth by health care providers. For the reasons discussed below, DTC telehealth platforms should re-visit their compliance plans and be prepared for increased state and federal regulatory scrutiny. Provider Licenses.

article thumbnail

HHS Issues HIPAA Guidance on Remote Communication Technologies for Audio-Only Telehealth

Health Care Law Brief

This guidance is a direct response to a December 2021 Executive Order that tasked HHS with developing HIPAA guidance for telehealth services, with the stated goals of improving “patient experience and convenience” as the COVID-19 public health emergency subsides.

HIPAA 52
article thumbnail

Episode 23: The Emerging Investigatory Focus on Telehealth: What You Need to Know

Healthcare Law Today

Maureen has extensive experience handling malicious insider matters ranging from employee fraud, embezzlement, and misappropriation to breaches of non-solicitation, non-compete and confidentiality agreements. Mark, how would you describe the current regulatory and legal environment for telemedicine companies? Mark Josephs.

article thumbnail

The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023

Drug & Device Law

2023) ( Buckman preemption barred MDL asserting fraud on EPA), cert. Negligence requires an evaluation of a defendant’s reasonableness, and all relevant NC authority includes relevant regulatory compliance in that mix. 19) Klinker v. Monsanto Co. , 4th 1261 (11th Cir. 4th 851 (6th Cir. denied , 144 S. 4th 696 (3d.

FDA 105